Patent protected technology
Immuron Limited
Immuron Limited
We are a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the development and commercialisation of a novel class of specifically targeted polyclonal antibodies that we believe can address significant unmet medical needs.
ASX : IMC
Patent protected technology
Patent protected technology
Our products
Our products are scientifically formulated using our patented technology platform to reduce diarrhoea, enhance gastrointestinal health, promote immune defence, and support liver and digestive health.
